 | • レポートコード：MRC2012A7228 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポリオウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ポリオウイルスワクチンの種類別市場規模（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別市場規模（公共用、私用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Bio-Med、Serum Institute、GSK、Panacea Biotec Ltd、Bibcol、IMBCA、Tiantan Biological、Halfkin Bio-Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・ポリオウイルスワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ポリオウイルスワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポリオウイルスワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポリオウイルスワクチンの南米市場（ブラジル、アルゼンチン） ・ポリオウイルスワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） ・用途別分析：公共用、私用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Poliovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Poliovirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Poliovirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Poliovirus Vaccine market has been segmented into
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
By Application, Poliovirus Vaccine has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Poliovirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Poliovirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Poliovirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Poliovirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Poliovirus Vaccine Market Share Analysis
Poliovirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Poliovirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Poliovirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Poliovirus Vaccine are:
Sanofi
Bio-Med
Serum Institute
GSK
Panacea Biotec Ltd
Bibcol
IMBCA
Tiantan Biological
Halfkin Bio-Pharmaceuticals
Among other players domestic and global, Poliovirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poliovirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine, with price, sales, revenue and global market share of Poliovirus Vaccine in 2018 and 2019.
Chapter 3, the Poliovirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Poliovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Poliovirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Poliovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poliovirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Poliovirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Poliovirus Vaccine Market
1.4.1 Global Poliovirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio-Med SWOT Analysis
2.2.4 Bio-Med Product and Services
2.2.5 Bio-Med Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Serum Institute
2.3.1 Serum Institute Details
2.3.2 Serum Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Serum Institute SWOT Analysis
2.3.4 Serum Institute Product and Services
2.3.5 Serum Institute Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Panacea Biotec Ltd
2.5.1 Panacea Biotec Ltd Details
2.5.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Panacea Biotec Ltd SWOT Analysis
2.5.4 Panacea Biotec Ltd Product and Services
2.5.5 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bibcol
2.6.1 Bibcol Details
2.6.2 Bibcol Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bibcol SWOT Analysis
2.6.4 Bibcol Product and Services
2.6.5 Bibcol Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 IMBCA
2.7.1 IMBCA Details
2.7.2 IMBCA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 IMBCA SWOT Analysis
2.7.4 IMBCA Product and Services
2.7.5 IMBCA Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tiantan Biological
2.8.1 Tiantan Biological Details
2.8.2 Tiantan Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Tiantan Biological SWOT Analysis
2.8.4 Tiantan Biological Product and Services
2.8.5 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Halfkin Bio-Pharmaceuticals SWOT Analysis
2.9.4 Halfkin Bio-Pharmaceuticals Product and Services
2.9.5 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Poliovirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Poliovirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Poliovirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Poliovirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Poliovirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Poliovirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Poliovirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Poliovirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Poliovirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Poliovirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Poliovirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Poliovirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Poliovirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Poliovirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Poliovirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Poliovirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Poliovirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Poliovirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Poliovirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Poliovirus Vaccine Price by Type (2015-2020)
11 Global Poliovirus Vaccine Market Segment by Application
11.1 Global Poliovirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Poliovirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Poliovirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Poliovirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Poliovirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Poliovirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Poliovirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Poliovirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Poliovirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Poliovirus Vaccine Market Forecast (2021-2025)
12.3 Poliovirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Poliovirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Poliovirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Poliovirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Poliovirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Poliovirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Poliovirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Poliovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Poliovirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Poliovirus Vaccine Major Business
Table 9. Sanofi Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Poliovirus Vaccine Product and Services
Table 12. Sanofi Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 14. Bio-Med Poliovirus Vaccine Major Business
Table 15. Bio-Med Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Bio-Med SWOT Analysis
Table 17. Bio-Med Poliovirus Vaccine Product and Services
Table 18. Bio-Med Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Poliovirus Vaccine Major Business
Table 21. Serum Institute Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Serum Institute SWOT Analysis
Table 23. Serum Institute Poliovirus Vaccine Product and Services
Table 24. Serum Institute Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GSK Basic Information, Manufacturing Base and Competitors
Table 26. GSK Poliovirus Vaccine Major Business
Table 27. GSK Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. GSK SWOT Analysis
Table 29. GSK Poliovirus Vaccine Product and Services
Table 30. GSK Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Panacea Biotec Ltd Poliovirus Vaccine Major Business
Table 33. Panacea Biotec Ltd Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Panacea Biotec Ltd SWOT Analysis
Table 35. Panacea Biotec Ltd Poliovirus Vaccine Product and Services
Table 36. Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bibcol Basic Information, Manufacturing Base and Competitors
Table 38. Bibcol Poliovirus Vaccine Major Business
Table 39. Bibcol Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Bibcol SWOT Analysis
Table 41. Bibcol Poliovirus Vaccine Product and Services
Table 42. Bibcol Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. IMBCA Basic Information, Manufacturing Base and Competitors
Table 44. IMBCA Poliovirus Vaccine Major Business
Table 45. IMBCA Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. IMBCA SWOT Analysis
Table 47. IMBCA Poliovirus Vaccine Product and Services
Table 48. IMBCA Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 50. Tiantan Biological Poliovirus Vaccine Major Business
Table 51. Tiantan Biological Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Tiantan Biological SWOT Analysis
Table 53. Tiantan Biological Poliovirus Vaccine Product and Services
Table 54. Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Major Business
Table 57. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Halfkin Bio-Pharmaceuticals SWOT Analysis
Table 59. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
Table 60. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Poliovirus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Poliovirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Poliovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 64. Global Poliovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 65. Global Poliovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 67. North America Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 68. North America Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 70. Europe Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 71. Europe Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 72. Europe Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Poliovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Poliovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Poliovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 77. South America Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 78. South America Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 84. Global Poliovirus Vaccine Sales by Type (2015-2020) (K Units)
Table 85. Global Poliovirus Vaccine Sales Share by Type (2015-2020)
Table 86. Global Poliovirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 87. Global Poliovirus Vaccine Revenue Share by Type (2015-2020)
Table 88. Global Poliovirus Vaccine Sales by Application (2015-2020) (K Units)
Table 89. Global Poliovirus Vaccine Sales Share by Application (2015-2020)
Table 90. Global Poliovirus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Poliovirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 92. Global Poliovirus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Poliovirus Vaccine Market Share Forecast by Type (2021-2025)
Table 94. Global Poliovirus Vaccine Sales Forecast by Application (2021-2025)
Table 95. Global Poliovirus Vaccine Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Poliovirus Vaccine Picture
Figure 2. Global Sales Market Share of Poliovirus Vaccine by Type in 2019
Figure 3. Inactivated Polio Vaccine (IPV) Picture
Figure 4. Oral Polio Vaccine (OPV) Picture
Figure 5. Poliovirus Vaccine Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Poliovirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Poliovirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Poliovirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Poliovirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Poliovirus Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Poliovirus Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Poliovirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Poliovirus Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Poliovirus Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Poliovirus Vaccine Revenue Market Share by Regions 2019
Figure 61. China Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Poliovirus Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Poliovirus Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Poliovirus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Poliovirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
不活化ポリオウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Inactivated Poliovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Inactivated Po…- 経口コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cholera Vaccine mar…
- 髄膜炎菌グループBワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Meningococcal Group B Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococcal G…
- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- 腸チフスVi多糖ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Typhoid Vi Polysaccharide Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Typhoid Vi …